Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Belgin Sever from Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey, to join the Editorial Board of Advances in Cells. Prof. Dr. Belgin Sever is currently an Associate Professor, at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University. Her research mainly focuses on the development of anticancer, antimicrobial, antidiabetic, anti-HIV, and anti-ALS drug candidates in particular based on medicinal chemistry and computational chemistry disciplines. She has published many high-quality articles in prestigious international peer-reviewed journals indexed by Science Citation Index (SCI) and SCI-Expanded. She was awarded the first rank in her graduation from Anadolu University, Faculty of Pharmacy in 2013. She received her MSc and PhD in Pharmaceutical Chemistry from Anadolu University, Faculty of Pharmacy in 2015 and in 2019, respectively. During her PhD, she deserved to be a scholarship holder of The Scientific and Technological Research Council of Turkey (TUBITAK) 2211-A National Scholarship Programme. After her PhD, she was accepted as a fellow of Takeda Science Foundation International Fellowship Program. As a post-doc fellow, she worked at Kumamoto University, Faculty of Life Sciences, Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Kumamoto, Japan from November 2020 to May 2021. She has been also accepted for TUBITAK 2219-International Postdoctoral Research Fellowship Program to work at the same Research Laboratory, Faculty of Life Sciences, Kumamoto University from June 2022 to June 2023. She was selected as a “Young Woman Researcher” in 7th Women Awards - Venus International Women Awards (VIWA) 2022” based on the VIWA 2022 Expert Committee Report and Apex Committee Recommendations. She was also awarded by Turkish Pharmacists' Association- Academy of Pharmacy in 2022 for her contributions to pharmaceutical science. She has been an Editorial Board member of Open Chemistry, Plos One, Heliyon-Pharmaceutical Science, Current Topics in Medicinal Chemistry, Frontiers in Chemistry, Frontiers in Chemical Biology, and Oncology Research. She has been also Guest Editor in Pharmaceuticals, Molecules and Frontiers in Chemistry. We appreciate Prof. Dr. Belgin Sever for her participation and support.